Quantum Corporation Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)

9 Months Ended

Dec. 31, 2023

Schedule of Basic and Diluted Net Income (Loss) Per Share

The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except per share data):


	Three Months Ended December 31,				Nine Months Ended December 31,
	2023		2022		2023		2022
			As Restated				As Restated
Numerator:
Net income (loss) attributable to common stockholders used in basic earnings per share	$	(9,869)	$	113	$	(22,342)	$	(8,190)
Add back: Excluded (gain) loss on assumed exercise of liability-classified common stock warrants during the period	—		—		—		(7,652)
Net income (loss) attributable to common stockholders used in diluted earnings per share	$	(9,869)	$	113	$	(22,342)	$	(15,842)


Denominator:
Weighted average common shares outstanding used in basic earnings per share	95,806		92,752		94,834		89,335
Incremental common shares from:
Assumed exercise of dilutive warrants	—		—		—		1,105
Weighted average common shares outstanding used in diluted earnings per share	95,806		92,752		94,834		90,440

Net income (loss) per share attributable to common stockholders - Basic	$	(0.10)	$	0.00	$	(0.24)	$	(0.10)
Net income (loss) per share attributable to common stockholders - Diluted	$	(0.10)	$	0.00	$	(0.24)	$	(0.18)

Schedule of Antidilutive Securities

The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):


	Three Months Ended December 31,		Nine Months Ended December 31,
	2023	2022	2023	2022
Stock Awards	7	2,110	331	2,480
Warrants	12,164	3,706	12,164	3,706